How Biological Age Is Actually Calculated: The 2026 Field Guide

What "biological age" actually means

If you ask ten longevity researchers to define biological age, you get ten subtly different answers — but they all agree on the framing: it's an estimate of how old your body looks at the molecular, physiological, or functional level, independent of how many birthdays you've had.

Three terms to keep straight:

• Chronological age — what your driver's license says.
• Biological age — the estimate. A 42-year-old whose biology "looks like" a typical 36-year-old has a biological age of 36.
• Age acceleration — biological age minus chronological age. Positive means you're aging faster than average; negative means slower.
• Pace of aging — separate concept introduced by the DunedinPACE clock. Tells you how many biological years you're racking up per chronological year. 1.0 = average; 1.2 = aging 20% faster. This is the version that interventions actually move.

The whole field exists because chronological age is a terrible predictor of anything you care about. Two 60-year-olds can have wildly different 10-year mortality risks; biological-age clocks try to put a number on that difference.

The three generations of clocks

Biological-age estimators sort cleanly into three generations based on what they were trained to predict.

First generation: predict chronological age

The original DNA-methylation clocks — Horvath 2013 (353 CpG sites, multi-tissue) and Hannum 2013 (71 CpG sites, blood only) — were trained on one target: predict the donor's chronological age from methylation patterns. Both achieved correlations of ~0.96 with age, with median errors of 3–5 years.

Conceptually they're elegant: aging leaves a chemical fingerprint on DNA, and you can read the fingerprint. But predicting chronological age is the wrong target if your goal is predicting health outcomes. By construction, a first-gen clock can't exceed chronological age as a mortality predictor — because that's what it was trained to be.

First-gen clocks still have research uses (cross-tissue comparisons, MyDNAge sells one), but the field has moved on. If a consumer product is selling you a "biological age" based on Horvath or Hannum alone, you're paying for the cheaper version of what's possible.

Second generation: predict mortality

The big break came with DNAm PhenoAge (Morgan Levine, 2018) and GrimAge (Ake Lu, 2019). Both train the methylation predictor on outcomes that matter:

• PhenoAge is a two-step construction. Step 1 takes 9 blood biomarkers and trains a "Phenotypic Age" against all-cause mortality in NHANES III (n ≈ 9,926, ~21 years of follow-up). Step 2 then trains a 513-CpG methylation predictor against that Phenotypic Age target. The result strongly predicts cancer, cardiovascular events, and dementia incidence.
• GrimAge goes further: it builds DNAm surrogates for 7 plasma proteins and a methylation-based estimator of smoking pack-years, then combines them via Cox regression directly against time-to-death in the Framingham cohort. It's the best single-timepoint mortality predictor in the published literature. GrimAge v2 (2022) improved performance in non-white cohorts.

Second-gen clocks finally made biological age clinically useful. They're what TruDiagnostic and NOVOS sell.

Third generation: pace of aging

DunedinPACE (Daniel Belsky, 2022) does something different. Instead of estimating an accumulated "age," it estimates the rate at which you're aging right now — expressed as biological years per chronological year.

The training data is special: the Dunedin Study cohort (New Zealand, born 1972–73) has had 19 biomarkers measured longitudinally at ages 26, 32, 38, and 45. DunedinPACE was trained to predict the slope of decline across those 19 markers from a single methylation snapshot.

Why this matters for intervention: an accumulated-age clock (Horvath, PhenoAge, GrimAge) is like an odometer — it summarizes total wear and changes slowly. A pace-of-aging measure is like a speedometer — it tells you whether what you're doing right now is accelerating or slowing your aging. The TAME-metformin trial and most current longevity studies use DunedinPACE as their outcome metric for exactly this reason.

DunedinPACE was also engineered for high test-retest reliability (ICC > 0.9), which the older clocks didn't always achieve.

The blood-only version you can actually run

Skip the methylation array for a moment. The blood-chemistry version of PhenoAge is the most underrated estimator in this space — it uses 9 markers from a standard panel and gives you a defensible biological age for $30–80.

The 9 inputs:

Marker	Source panel
Albumin	CMP
Creatinine	CMP
Glucose	CMP
C-reactive protein (CRP, ln-transformed)	hs-CRP
Lymphocyte percentage	CBC
MCV (mean cell volume)	CBC
RDW (red cell distribution width)	CBC
Alkaline phosphatase	CMP
White blood cell count	CBC

Plus your chronological age. The Levine 2018 formula is fully published:

xb = -19.9067
     - 0.0336 × albumin
     + 0.0095 × creatinine
     + 0.1953 × glucose
     + 0.0954 × ln(CRP)
     - 0.0120 × lymphocyte%
     + 0.0268 × MCV
     + 0.3306 × RDW
     + 0.00188 × ALP
     + 0.0554 × WBC
     + 0.0804 × age

M = 1 - exp( -exp(xb) × (exp(120 × 0.0076927) - 1) / 0.0076927 )

PhenoAge = 141.50225 + ln(-0.00553 × ln(1 - M)) / 0.09165

Validation: in NHANES IV, every 5 years of PhenoAge advance roughly doubles all-cause mortality odds. Replicated in UK Biobank and the Health and Retirement Study.

Costs: $30–80 for the lab panel at LabCorp / Quest, free if you upload existing labs your doctor already ordered. The BioAge R package (Kwon & Belsky 2021) implements this and a couple of related composites.

What the consumer apps actually do

Here's what's under the hood at the products you've heard of.

Product	Substrate	Underlying method	Price	Honest?
TruDiagnostic TruAge	Blood DNAm	PhenoAge + GrimAge + DunedinPACE + OMICmAge + SYMPHONYAge	$229–499	Yes — names every clock and links the papers
NOVOS Age	Blood DNAm	DunedinPACE + Organ Age + telomere	~$499	Yes
Elysium Index	Saliva DNAm	Custom clock developed with Morgan Levine	$299–499	Yes — peer-reviewed
MyDNAge	Blood/urine DNAm	Horvath 2013 (first-gen)	$299	Honest, but selling first-gen tech
InsideTracker InnerAge 2.0	Blood (17 markers)	Klemera-Doubal method + proprietary	$249–589	Above-average — names the academic basis
Bryan Johnson's Speed of Aging	Blood DNAm	TruDiagnostic underneath (DunedinPACE + SYMPHONYAge)	~$299	Underlying tech is gold standard; Johnson's personal interpretation ("I reversed aging by 31 years") has been critiqued by aging researchers
GlycanAge	Finger-prick (IgG glycans)	29-glycan proprietary; ~140 peer-reviewed papers	$348	Yes — differentiated substrate
Function Health	Blood (100+ markers)	Proprietary formula. Function itself states the age score "is not a clinical measure."	$365/yr	Low — sold as a clinical measure de facto
Lifeforce	Blood (40-50 markers)	No explicit clock — sells biomarker dashboard + clinician access	$129/mo + setup	N/A as a clock
WHOOP Age	Wearable behavior	9-metric composite (sleep, HR zones, steps, RHR, VO₂max, lean mass)	$199–359/yr	Medium — it's really a "behavioral age"
Oura Cardiovascular Age	Finger PPG	Pulse-wave-velocity proxy from overnight PPG morphology	Ring $349+ + $5.99/mo	Medium — labels it Cardiovascular Age (not Biological Age), which is honest, but the PPG-to-PWV mapping isn't independently validated
Apple Watch Cardio Fitness	Wrist HR + GPS	VO₂max estimate via NN + physiological ODE	Free with Watch	High — they correctly don't call it biological age
Garmin Fitness Age	Wearable	Literally VO₂max repackaged against age/sex norms	Free with device	Most honest naming in the category

The pattern: the more honest the product is about what it's actually measuring, the less marketing-friendly the number sounds. "Cardiovascular Age" and "Fitness Age" don't generate the same wow factor as "Biological Age" — but they're what those products are really measuring.

Can a wearable plus a questionnaire get you close?

The short answer: yes, for an educational estimate. Not a clinical-grade one.

Here's why. The strongest single mortality predictor in the published literature is cardiorespiratory fitness. Mandsager et al. (2018, JAMA Network Open, n=122,000) tracked patients undergoing exercise treadmill testing and found the lowest-fitness quintile had ~5× the mortality rate of the elite quintile. Apple Watch's Cardio Fitness gives you a VO₂max estimate within about ±1.2 mL/kg/min of a lab cardiopulmonary exercise test (per Apple's own validation paper).

Stack a few more high-signal inputs on top:

• Sleep regularity — Windred et al. (2024, SLEEP) found regularity is a stronger mortality predictor than duration itself. Self-rateable in one question.
• Sleep duration — Yin 2017 J Am Heart Assoc: U-shape with optimum at 7–8 hours.
• Resting heart rate — Aune 2017 BMC Medicine: each 10-bpm increase above ~65 is associated with ~17% higher all-cause mortality.
• Daily steps — Paluch 2022 Lancet Public Health: clear dose-response through ~10,000 steps.
• Strength training frequency — Saeidifard 2019 meta-analysis: 2–3 sessions/week reduce all-cause mortality by ~21%.
• BMI + waist circumference — Aune 2016 BMJ (BMI U-shape) and Janssen 2004 AJCN (waist independent of BMI).
• The lifestyle Big Four: smoking, alcohol, diet quality, stress.

That's 18 inputs total. None require a blood draw. All are self-reportable in two minutes, and most are already in Apple HealthKit if the user owns a Watch.

The honest framing: the absolute number will be ±5 years off because of self-report bias. But the relative ranking across dimensions — which factor is dragging you down most, which one is buying you the most years back — is robust, because it's reading directly off the cohort-level evidence.

So what should you actually do?

A practical decision tree, depending on how seriously you want to engage with this:

If you're curious but not paying $200+ for a test. Use a free self-report estimator that's grounded in published research. We built one — 18 inputs, fully cited, 2 minutes, no signup, no blood test, the per-dimension breakdown shows you exactly which factor is your single biggest lever.

If you have recent bloodwork from a doctor's visit. Run the Levine PhenoAge formula on it. Free tools exist online; the math is published. You'll get a number that's actually validated against ~20-year mortality outcomes in NHANES III.

If you're tracking an intervention (caloric restriction, GLP-1, an exercise program) and want a real outcome metric. Get a TruDiagnostic TruAge (DunedinPACE) test. The pace-of-aging clock is the only one in the literature that moves meaningfully on a 6–12-month timescale. Retest every 3–6 months.

If you want the single strongest mortality-prediction number with one blood draw. GrimAge via TruDiagnostic or NOVOS. It's the heaviest hitter for single-snapshot mortality prediction in the published literature.

If your insurance covers it. Some clinics now offer biological-age testing under wellness benefits. Ask.

What this whole field is missing

A few caveats no one in the consumer space talks about much:

1. Ethnicity bias. Almost every clock was trained on predominantly European-ancestry cohorts. Recent work (e.g. 2023 eBioMedicine refitting KDM and PhenoAge in Chinese adults) finds meaningfully different coefficients. If you're East Asian, South Asian, or African-ancestry, expect ±3–5 years of systematic error on top of everything else.
2. Test-retest reliability. First-gen clocks (Horvath, Hannum) can vary 3–9 years between technical replicates of the same blood sample. That number alone should make you suspicious of any "I dropped 4 years!" anecdote that wasn't done on DunedinPACE (ICC > 0.9) or similar high-reliability second/third-gen clocks.
3. Intervention sensitivity is modest. Even successful interventions (caloric restriction in CALERIE-2, exercise programs, GLP-1 agonists) typically move DunedinPACE by 0.03–0.05 over 6–12 months. Real, replicable, but not the "10 years younger" headlines suggest.
4. "Biological age" has no FDA-recognized clinical use. All consumer claims have to be wellness-framed. This is also why every product has a "not medical advice" disclaimer.

Bottom line

Biological-age estimation is real science with a real evidence base. It's also a marketing category, and the gap between those two is where most consumers get lost.

If you want the gold-standard number: DNA-methylation, GrimAge or DunedinPACE, $200–$500, via TruDiagnostic or NOVOS.

If you have recent blood work: Levine PhenoAge from your CBC + CMP. Free if you have the values.

If you want a 2-minute estimate with no blood draw: a self-report tool grounded in cohort studies. Try ours, free; the underlying scoring engine is open source (github.com/YusongCui/biological-age-calculator) so you can read every coefficient and the paper behind it.

The most useful number isn't the headline age. It's the per-dimension breakdown: which lifestyle factor is your single biggest lever right now. That's what intervention studies actually move.

---

For full citations and the underlying scoring algorithm, see the open-source skill at github.com/YusongCui/biological-age-calculator.